Johnson & Johnson R&D Symposium 2026, Beerse
Meet Nygen at the Johnson & Johnson R&D Symposium 2026 in Beerse, Belgium, June 18. Parashar Dhapola, CEO, will be on site for conversations on single-cell analytics and virtual biology for drug discovery.
Symposium overview
The Johnson & Johnson R&D Symposium 2026 is themed Virtual Biology: From Cells to Patients – Transforming Data into Translational Insights and Patient Impact. The annual gathering brings together researchers, clinicians, and industry leaders for a full day on how multi-scale biological data and advanced computational approaches are driving actionable preclinical insights, accelerating clinical research, and improving patient outcomes.
The programme explores virtual biology from the cell, organ, and patient perspectives, with speakers spanning organoid biology, in silico discovery, quantitative systems pharmacology, computational systems biology, and translational AI.
Date: Thursday, June 18, 2026, 9:00 AM to 6:00 PM CEST.
Venue
Johnson & Johnson
Turnhoutseweg 30, 2340 Beerse, Belgium
Practical information and the programme are on the official symposium site.
Nygen at the symposium
Parashar Dhapola, PhD, CEO, will be on site for conversations on single-cell analytics, evidence-based cell type annotation, and how discovery teams are connecting cellular data to translational insight within virtual biology workflows.
Meet our team
To pre-book a meeting during the symposium, email parashar.dhapola@nygen.io and we will confirm a slot that fits your agenda.
Registration
Delegate registration on the official symposium site is currently closed. For attendance questions, contact Helga Van Dooren at hvdooren@its.jnj.com.
